REGISTERED
on 02 Jul 2019
Last Applicant/ Owned by
ALEXANDER FLEMINGLAAN 1
DELFT
NL
2613AX
Serial Number
88092209 filed on 24th Aug 2018
Registration Number
5792169 registered on 02th Jul 2019
Correspondent Address
Duane M. Byers
Filing Basis
No Filing Basis
Disclaimer
NO DATA
PURICILLIN
Chemical and biochemical products for use in the pharmaceutical industry, namely, chemical and biochemical additives for use in the manufacture of pharmaceuticals Chemical and biochemical products for pharmaceutical use, namely, penicillin preparations, antibiotics and chemical and biochemical preparations for treating bacterial infections
Classification Information
Class [005]
Pharmaceutical Products
Chemical and biochemical products for pharmaceutical use, namely, penicillin preparations, antibiotics and chemical and biochemical preparations for treating bacterial infections
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Chemical and biochemical products for use in the pharmaceutical industry, namely, chemical and biochemical additives for use in the manufacture of pharmaceuticals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 88092209
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 6583-0009
44D Filed
No
44D Current
No
44E filed
Yes
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Jul 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 02th Jul 2019 | REGISTERED-PRINCIPAL REGISTER |
| 17th Apr 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 16th Apr 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 16th Apr 2019 | PUBLISHED FOR OPPOSITION |
| 27th Mar 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 12th Mar 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 11th Mar 2019 | EXAMINER'S AMENDMENT ENTERED |
| 11th Mar 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 11th Mar 2019 | EXAMINERS AMENDMENT E-MAILED |